Abstract:The use of existing mouse models in cancer research is of utmost importance as they aim to explore the casual link between candidate cancer genes and carcinogenesis as well as to provide models to develop and test new therapies. However, faster progress in translating mouse cancer model research into the clinic has been hampered due to the limitations of these models to better reflect the complexities of human tumors. Traditionally, immunocompetent and immunodeficient mice with syngeneic and xenografted tumors transplanted subcutaneously or orthotopically have been used. These models are still being widely employed for many different types of studies, in part due to their widespread availability and low cost. Other types of mouse models used in cancer research comprise transgenic mice in which oncogenes can be constitutively or conditionally expressed and tumor-suppressor genes silenced using conventional methods, such as retroviral infection, microinjection of DNA constructs, and the so-called "gene-targeted transgene" approach. These traditional transgenic models have been very important in studies of carcinogenesis and tumor pathogenesis, as well as in studies evaluating the development of resistance to therapy. Recently, the clustered regularly interspaced short palindromic repeats (CRISPR)-based genome editing approach has revolutionized the field of mouse cancer models and has had a profound and rapid impact on the development of more effective systems to study human cancers. The CRISPR/Cas9-based transgenic models have the capacity to engineer a wide spectrum of mutations found in human cancers and provide solutions to problems that were previously unsolvable. Recently, humanized mouse xenograft models that accept patient-derived xenografts and CD34+ cells were developed to better mimic tumor heterogeneity, the tumor microenvironment, and cross-talk between the tumor and stromal/immune cells. These features make them extremely valuable models for the evaluation of investigational cancer therapies, specifically new immunotherapies. Taken together, improvements in both the CRISPR/Cas9 system producing more valid mouse models and in the humanized mouse xenograft models resembling complex interactions between the tumor and its environment might represent one of the successful pathways to precise individualized cancer therapy, leading to improved cancer patient survival and quality of life.

Genetically defined mouse models that mimic natural aspects of human prostate cancer development.

Diverse Landscape of Genetically Engineered Mouse Models: Genomic and Molecular Insights into Prostate Cancer

Clinically relevant humanized mouse models of metastatic prostate cancer facilitate therapeutic evaluation

In Vivo Models for Prostate Cancer Research

Advances in Prostate Cancer Research Models: from Transgenic Mice to Tumor Xenografting Models

An overview of the latest in state-of-the-art murine models for prostate cancer

If you give a mouse a mutation: comparing the therapeutic utility of renowned mouse models of human cancers

Mouse Models for Multistep Tumorigenesis

LONGITUDINAL COHORT ANALYSIS OF LETHAL PROSTATE CANCER PROGRESSION IN TRANSGENIC MICE

Modelling aggressive prostate cancers of young men in immune-competent mice, driven by isogenic Trp53 alterations and Pten loss

Patient-derived Human Tumour Tissue Xenografts in Immunodeficient Mice: a Systematic Review

Transgenic Mouse Models in Cancer Research

Transgenic Murine Models of Human Cancer: Bridging the Gap from Mouse to Man

Prostate cancer xenografts and hormone induced prostate carcinogenesis

Deletion of tumor suppressors adenomatous polyposis coli and Smad4 in murine luminal epithelial cells causes invasive prostate cancer and loss of androgen receptor expression

A mouse model of prostate cancer bone metastasis in a syngeneic immunocompetent host

Mouse Models in Prostate Cancer Translational Research: From Xenograft to PDX

Comprehensive genotypic analysis of human prostate cancer cell lines and sublines derived from metastases after orthotopic implantation in nude mice

Humanized mouse models: A valuable platform for preclinical evaluation of human cancer

Genetically engineered mouse models in oncology research and cancer medicine

[Application and Recent Advances of Laboratory Mouse in Human Cancer Research].